CSANZ 2022

Beth Habecker

Oregon Health and Science University, USA

Dr Habecker is Professor of Chemical Physiology and Biochemistry at Oregon Health & Science University, with a joint appointment in Medicine (Knight Cardiovascular Institute). She is Co-Director of PMedIC, which is a joint research collaboration between OHSU and the Pacific Northwest National Laboratory.  Dr Habecker received her PhD in Pharmacology from the University of Washington in Seattle and carried out postdoctoral training in Neuroscience with Dr Story Landis at Case Western Reserve University and the National Institute of Neurological Disorders and Stroke. Her laboratory investigates sympathetic neuron-target interactions in injury and disease, with a particular focus on myocardial infarction and the changes that occur in cardiac sympathetic nerves after MI. Her lab has identified mechanisms involved in axon degeneration, axon sprouting/ regeneration, and alterations in neurotransmitter and peptide production.  They have also connected changes in cardiac sympathetic nerves to alterations in arrhythmia susceptibility and cardiac inflammation. Her research contributed to the development of a novel therapeutic being tested in phase I clinical trial. She is a reviewing editor for the Journal of Physiology, Past President of the Catecholamine Society, and served on the Neural Control and Autonomic Regulation Steering Committee of the American Physiological Society. 

To view scheduled presentations for invited speakers, please click here.  

Back to speakers